(DBK) Deutsche Bank - Overview
Stock: Banking, Investment, Asset, Wealth
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.82% |
| Yield on Cost 5y | 8.67% |
| Yield CAGR 5y | 50.37% |
| Payout Consistency | 78.7% |
| Payout Ratio | 19.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 39.9% |
| Relative Tail Risk | -8.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.58 |
| Alpha | 63.58 |
| Character TTM | |
|---|---|
| Beta | 0.440 |
| Beta Downside | 0.662 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.63% |
| CAGR/Max DD | 1.60 |
Description: DBK Deutsche Bank January 27, 2026
Deutsche Bank AG (XETRA: DBK) is a diversified financial services group headquartered in Frankfurt, operating four main segments: Corporate Bank (risk-management, cash-management, trade finance and lending), Investment Bank (debt origination, M&A advisory, FX and equity-capital markets), Private Bank (wealth-management, ESG-focused investment products and retail banking services) and Asset Management (alternatives, real-estate, infrastructure, sustainable-investment solutions and pension/insurance advisory).
According to the Q4 2025 earnings release (published Feb 2026), the bank reported a net profit of €3.1 billion, a 7 % YoY increase, driven by a 12 % rise in Investment-Bank revenue and a 5 % improvement in the Corporate-Bank cost-to-income ratio (down to 71 %). The CET1 capital ratio held at 14.8 % and ROE stabilized at 9.2 %, reflecting a solid capital position amid a low-interest-rate environment in the Eurozone.
Key macro drivers for the European regional-bank sector remain the European Central Bank’s policy stance-its recent decision to keep the policy rate at 3.75 % to curb inflation-supporting net-interest-margin recovery, while heightened regulatory scrutiny on climate-risk disclosures is accelerating the Private-Bank’s ESG-product rollout.
For a deeper dive into Deutsche Bank’s valuation dynamics and scenario analysis, a quick look at ValueRay’s model could be a useful next step.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 5.73b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -2.47 > 1.0 |
| NWC/Revenue: -1049 % < 20% (prev 821.1%; Δ -1870 % < -1%) |
| CFO/TA -0.00 > 3% & CFO -2.93b > Net Income 5.73b |
| Net Debt (-16.18b) to EBITDA (8.29b): -1.95 < 3 |
| Current Ratio: 0.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.00b) vs 12m ago -1.30% < -2% |
| Gross Margin: 48.35% > 18% (prev 0.65%; Δ 4770 % > 0.5%) |
| Asset Turnover: 4.46% > 50% (prev 4.13%; Δ 0.32% > 0%) |
| Interest Coverage Ratio: -0.61 > 6 (EBITDA TTM 8.29b / Interest Expense TTM 30.16b) |
Altman Z'' -3.06
| A: -0.47 (Total Current Assets 191.51b - Total Current Liabilities 838.92b) / Total Assets 1391.25b |
| B: 0.02 (Retained Earnings 26.59b / Total Assets 1391.25b) |
| C: -0.01 (EBIT TTM -18.32b / Avg Total Assets 1385.67b) |
| D: 0.02 (Book Value of Equity 27.50b / Total Liabilities 1312.37b) |
| Altman-Z'' Score: -3.06 = D |
Beneish M -2.51
| DSRI: 0.89 (Receivables 1.44b/1.50b, Revenue 61.74b/57.02b) |
| GMI: 1.34 (GM 48.35% / 64.99%) |
| AQI: 1.40 (AQ_t 0.86 / AQ_t-1 0.61) |
| SGI: 1.08 (Revenue 61.74b / 57.02b) |
| TATA: 0.01 (NI 5.73b - CFO -2.93b) / TA 1391.25b) |
| Beneish M-Score: -2.51 (Cap -4..+1) = A |
What is the price of DBK shares?
Over the past week, the price has changed by -6.16%, over one month by -6.47%, over three months by -0.22% and over the past year by +71.93%.
Is DBK a buy, sell or hold?
What are the forecasts/targets for the DBK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.2 | 6.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 45.2 | 44.8% |
DBK Fundamental Data Overview February 01, 2026
P/E Trailing = 13.2669
P/E Forward = 9.8328
P/S = 2.0937
P/B = 0.8014
P/EG = 0.4869
Revenue TTM = 61.74b EUR
EBIT TTM = -18.32b EUR
EBITDA TTM = 8.29b EUR
Long Term Debt = 230.03b EUR (from longTermDebt, last quarter)
Short Term Debt = 18.06b EUR (from shortTermDebt, last quarter)
Debt = 131.83b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -16.18b EUR (from netDebt column, last quarter)
Enterprise Value = 5.38b EUR (63.62b + Debt 131.83b - CCE 190.07b)
Interest Coverage Ratio = -0.61 (Ebit TTM -18.32b / Interest Expense TTM 30.16b)
EV/FCF = -0.18x (Enterprise Value 5.38b / FCF TTM -29.11b)
FCF Yield = -541.0% (FCF TTM -29.11b / Enterprise Value 5.38b)
FCF Margin = -47.15% (FCF TTM -29.11b / Revenue TTM 61.74b)
Net Margin = 9.28% (Net Income TTM 5.73b / Revenue TTM 61.74b)
Gross Margin = 48.35% ((Revenue TTM 61.74b - Cost of Revenue TTM 31.89b) / Revenue TTM)
Gross Margin QoQ = 50.45% (prev 49.23%)
Tobins Q-Ratio = 0.00 (Enterprise Value 5.38b / Total Assets 1391.25b)
Interest Expense / Debt = 5.35% (Interest Expense 7.05b / Debt 131.83b)
Taxrate = 25.60% (626.0m / 2.44b)
NOPAT = -13.63b (EBIT -18.32b * (1 - 25.60%)) [loss with tax shield]
Current Ratio = 0.23 (Total Current Assets 191.51b / Total Current Liabilities 838.92b)
Debt / Equity = 1.70 (Debt 131.83b / totalStockholderEquity, last quarter 77.38b)
Debt / EBITDA = -1.95 (Net Debt -16.18b / EBITDA 8.29b)
Debt / FCF = 0.56 (negative FCF - burning cash) (Net Debt -16.18b / FCF TTM -29.11b)
Total Stockholder Equity = 77.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.41% (Net Income 5.73b / Total Assets 1391.25b)
RoE = 7.36% (Net Income TTM 5.73b / Total Stockholder Equity 77.90b)
RoCE = -5.95% (EBIT -18.32b / Capital Employed (Equity 77.90b + L.T.Debt 230.03b))
RoIC = -6.41% (negative operating profit) (NOPAT -13.63b / Invested Capital 212.58b)
WACC = 5.14% (E(63.62b)/V(195.45b) * Re(7.54%) + D(131.83b)/V(195.45b) * Rd(5.35%) * (1-Tc(0.26)))
Discount Rate = 7.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -2.25%
Fair Price DCF = unknown (Cash Flow -29.11b)
EPS Correlation: 19.02 | EPS CAGR: 10.17% | SUE: -0.15 | # QB: 0
Revenue Correlation: 65.12 | Revenue CAGR: 21.83% | SUE: 0.58 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.99 | Chg30d=-0.076 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=3.37 | Chg30d=-0.001 | Revisions Net=+2 | Growth EPS=+5.5% | Growth Revenue=+3.0%
EPS next Year (2027-12-31): EPS=3.85 | Chg30d=+0.094 | Revisions Net=+4 | Growth EPS=+14.2% | Growth Revenue=+4.0%